Clinical Trials Logo

Propofol Adverse Reaction clinical trials

View clinical trials related to Propofol Adverse Reaction.

Filter by:
  • None
  • Page 1

NCT ID: NCT05502458 Completed - Clinical trials for Hepatocellular Carcinoma

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

To investigate the effects of perioperative anesthetic drugs propofol and desflurane on circulating tumor nucleic acids (CK7, ELF3, EGFR and EphB4 mRNA) in the blood of patients with liver cancer, so as to provide scientific reference for clinical anesthesia in the perioperative treatment of tumor

NCT ID: NCT05358535 Recruiting - Anesthesia Clinical Trials

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

PEAC
Start date: September 19, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).

NCT ID: NCT05046054 Recruiting - Pain Clinical Trials

The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Propofol, an intravenous sedative agent, frequently produces pain during injection. This study was designed to investigate whether transcutaneous electrical nerve stimulation could reduce pain during propofol injection. in minimizing propofol injection pain.

NCT ID: NCT04727034 Recruiting - Gastric Cancer Clinical Trials

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

Propofol is the most commonly used intravenous anesthetic for painless gastroscopy, but propofol significantly inhibits the respiratory and circulatory systems. Therefore, the incidence of intraoperative hypoxemia and hypotension is high. Remazolam tosylate is an ultra-short-acting benzodiazepine drug, which has a mild inhibitory effect on the respiratory and circulatory systems and has anterograde amnesia. These advantages make remazolam tosylate very likely to replace propofol in painless gastroscopic anesthesia.

NCT ID: NCT04455776 Completed - Clinical trials for Sedation Complication

Safety Evaluation of Propofol Sedation for Magnetic Resonance Imaging in Pediatric Patients

Start date: July 3, 2020
Phase:
Study type: Observational

Propofol is often used for sedation in children undergoing magnetic resonance imaging. The investigators will perform a chart review of 4 month of activity (about 100 cases) and review the incidence and severity of adverse events of this sedation technique.

NCT ID: NCT04194151 Completed - Anesthesia Clinical Trials

Impact of Propofol Reduction in Anesthesia Induction

Start date: November 1, 2017
Phase: Phase 4
Study type: Interventional

Objective: Determine if, by reducing the dose of propofol and increasing the time elapsed between fentanyl and propofol administration, hemodynamic response is improved. Methods: Patients were randomized into time groups (2 and 1 minute) and each subdivided into dose groups (1, 1.5 and 2 mg kg-1) obtaining six time-dose groups. After receiving 2 μg kg-1 of fentanyl, propofol was administered after the predetermined time. Time to hypnosis (BIS<60) and hemodynamic parameters at pre-induction, pre-intubation and postintubation were registered.

NCT ID: NCT04078087 Completed - Clinical trials for Propofol Adverse Reaction

The Effect of Body Mass Index In Relation To Menstrual Cycle Phase on Propofol Injection Pain

Start date: February 1, 2020
Phase:
Study type: Observational

There are suggestions from experimental pain studies that pain perception in patients with severe obesity differs compared with individuals with lower BMI values, with a tendency for patients with severe obesity to be hypoalgesic - that is, to have reduced numerical pain scores to a variety of painful stimuli. That finding could be related to: associated reduced cognitive function (complex attention, verbal and visual memory, and decision making) in severe obesity. The purpose of this study is to determine differences between females' pain levels whether they are obese or non-obese, during different menstrual phases (premenstrual, postmenstrual and menopausal phases) through propofol injection pain given for induction of GA